Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Testing effectiveness (Phase 2)Study completedNCT00006102What this trial is testingRebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more National Cancer Institute (NCI) 200
Not applicableStudy completedNCT00005881What this trial is testingQuality of Life in Children Treated for CancerWho this might be right forLeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific Children's Oncology Group 538
Large-scale testing (Phase 3)Study completedNCT00261677What this trial is testingEvaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing ChemotherapyWho this might be right forAnemiaHodgkin DiseaseLeukemia+1 more Ortho Biotech Products, L.P. 224
Early research (Phase 1)Study completedNCT00003970What this trial is testingGenetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00002625What this trial is testingTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forEsophageal CancerLung CancerLymphoma National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Testing effectiveness (Phase 2)Ended earlyNCT03207867What this trial is testingNIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaWho this might be right forNSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more Novartis Pharmaceuticals 315
Early research (Phase 1)Study completedNCT00293345What this trial is testing3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT02508038What this trial is testingAlpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid TumorsWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more University of Wisconsin, Madison 22
Not applicableStudy completedNCT00899496What this trial is testingLaboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy ParticipantsWho this might be right forCancer Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Ended earlyNCT04775680What this trial is testingStudy of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin LymphomaWho this might be right forSolid TumorNon Hodgkin Lymphoma Adagene (Suzhou) Limited 25
Early research (Phase 1)Study completedNCT01356173What this trial is testingEvaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma, Solid Tumor Genentech, Inc. 10
Testing effectiveness (Phase 2)Looking for participantsNCT04390737What this trial is testingEvaluate the Safety and Clinical Activity of HH2853Who this might be right forFL LymphomaEpithelioid SarcomaPeripheral T Cell Lymphoma+1 more Haihe Biopharma Co., Ltd. 254
Early research (Phase 1)UnknownNCT00003073What this trial is testingChemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid TumorsWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+1 more Pacira Pharmaceuticals, Inc 15
Early research (Phase 1)Ended earlyNCT00933985What this trial is testingObatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaWho this might be right forAcute Leukemias of Ambiguous LineageAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+26 more National Cancer Institute (NCI) 22
Very early researchActive Not RecruitingNCT01269593What this trial is testingPET Imaging of Cancer Patients Using 124I-PUH71: A Pilot StudyWho this might be right forNon-Hodgkin's LymphomaMyelomaActive Solid Malignancy Memorial Sloan Kettering Cancer Center 63
Early research (Phase 1)Study completedNCT00002759What this trial is testingIrinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaWho this might be right forDrug/Agent Toxicity by Tissue/OrganLymphomaNeutropenia+2 more National Cancer Institute (NCI) 3
Not applicableUnknownNCT00072488What this trial is testingWhole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or LymphomaWho this might be right forLymphomaNeuroblastomaSarcoma American College of Radiology Imaging Network 226
Testing effectiveness (Phase 2)Study completedNCT00003406What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Cancer Treatment Centers of America 30